Skip to main content
Premium Trial:

Request an Annual Quote

VTT of Finland Licenses GeneGo's Software for Cancer Studies

NEW YORK (GenomeWeb News) – GeneGo said today that the VTT Technical Research Centre of Finland, a developer of novel high-throughput methods for cancer research, drug discovery, and diagnostics, has licensed the company’s software suite.
 
Under the agreement, VTT will use the MetaCore and MetaDrug software in compound screening, RNA interference experiments, cell biology, and bioinformatics projects to identify pathways and networks for cancer research projects.
 
These projects include studies of the mechanisms of cancer development and progression, therapeutics research, and the actions of anti-cancer compounds.
 
VTT’s Medical Biotechnology Knowledge Centre is funded by the European Commission and the Academy of Finland.
 
Financial terms of the agreement were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.